Literature DB >> 2874581

Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats: possible role of dopamine.

E M Pich, R Samanin.   

Abstract

Low doses of buspirone, haloperidol and sulpiride were compared with diazepam in two experimental models of anxiety in rats. In a conflict test, 0.6 and 1.2 mg/kg buspirone, 0.05 and 0.10 mg/kg haloperidol and 0.5 mg/kg sulpiride significantly increased punished responding. Buspirone 1.2 and 2.5 mg/kg significantly reduced the number of unpunished responses while haloperidol and sulpiride at the doses tested had no effect. Effects on punished responding were seen in a narrow dose range and were less pronounced with these drugs than with diazepam. Similar results were obtained with rats', activity in the two-compartment exploratory test. At doses causing no change in the locomotion of rats in photocell activity cages, buspirone (0.1 mg/kg), haloperidol (0.025-0.100 mg/kg) and sulpiride (0.5-1.0 mg/kg) significantly increased the number of crossings between the two compartments. Again, the peak effects were small when compared with the effect of diazepam and the active dose range was very narrow. Apomorphine 0.2 mg/kg SC significantly counteracted the effect of 0.1 mg buspirone and 1.0 mg/kg sulpiride in the two-compartment exploratory test with no effect on 2.5 mg/kg diazepam. The data show that buspirone, in a narrow dose range, shows disinhibitory effects in experimental models of anxiety. Similar effects are shown by low doses of haloperidol and sulpiride. It is suggested that buspirone and sulpiride produce these disinhibitory effects by blocking particular dopamine receptors in the brain, possibly those located in the nerve terminals, but it is likely that other mechanisms, particularly serotonin, are involved in the effects of buspirone in anxious states.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2874581     DOI: 10.1007/bf00175204

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  35 in total

1.  Clinical study of proclorperazine, a new tranquilizer for the treatment of nonhospitalized psychoneurotic patients.

Authors:  T J VISCHER
Journal:  N Engl J Med       Date:  1957-01-03       Impact factor: 91.245

2.  Low-dose neuroleptic regimens in the treatment of borderline patients.

Authors:  J R Brinkley; B D Beitman; R O Friedel
Journal:  Arch Gen Psychiatry       Date:  1979-03

3.  [The influence of sulpiride on motor activity and vigilance in the mouse].

Authors:  C Laville; J Margarit
Journal:  Pathol Biol       Date:  1968 Jun-Jul

4.  Effects of combined treatment with trifluoperazine-HCl and amobarbital on punished behavior in rats.

Authors:  A B Davidson; L Cook
Journal:  Psychopharmacologia       Date:  1969

5.  Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the nucleus accumbens: drug interaction at presynaptic receptors?

Authors:  B Costall; D H Fortune; S C Hui; R J Naylor
Journal:  Eur J Pharmacol       Date:  1980-05-16       Impact factor: 4.432

6.  The involvement of nigral serotonin innervation in the control of punishment-induced behavioral inhibition in rats.

Authors:  M H Thiébot; M Hamon; P Soubrié
Journal:  Pharmacol Biochem Behav       Date:  1983-08       Impact factor: 3.533

7.  A double-blind comparison of sulpiride with chlordiazepoxide in neurosis.

Authors:  M Toru; H Moriya; K Yamamoto; Y Shimazono
Journal:  Folia Psychiatr Neurol Jpn       Date:  1976

8.  Time course of rat motility response to apomorphine: a simple model for studying preferential blockade of brain dopamine receptors mediating sedation.

Authors:  N Montanaro; A Vaccheri; R Dall'Olio; O Gandolfi
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

9.  Buspirone and diazepam in anxiety: a controlled study.

Authors:  K Rickels; K Weisman; N Norstad; M Singer; D Stoltz; A Brown; J Danton
Journal:  J Clin Psychiatry       Date:  1982-12       Impact factor: 4.384

Review 10.  Receptors for the age of anxiety: pharmacology of the benzodiazepines.

Authors:  J F Tallman; S M Paul; P Skolnick; D W Gallager
Journal:  Science       Date:  1980-01-18       Impact factor: 47.728

View more
  17 in total

1.  Anti-conflict efficacy of buspirone following acute versus chronic treatment.

Authors:  D M Schefke; D J Fontana; R L Commissaris
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Sulpiride and refractory panic disorder.

Authors:  Emerson A Nunes; Rafael C Freire; Moema Dos Reis; Adriana Cardoso de Oliveira E Silva; Sérgio Machado; José A S Crippa; Serdar M Dursun; Glen B Baker; Jaime E C Hallak; Antonio E Nardi
Journal:  Psychopharmacology (Berl)       Date:  2012-08-05       Impact factor: 4.530

3.  Prevention of the analgesic consequences of social defeat in male mice by 5-HT1A anxiolytics, buspirone, gepirone and ipsapirone.

Authors:  R J Rodgers; J K Shepherd
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  The discriminative stimulus properties of buspirone involve dopamine-2 receptor antagonist activity.

Authors:  H J Rijnders; J L Slangen
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron.

Authors:  E C Warburton; M H Joseph; J Feldon; I Weiner; J A Gray
Journal:  Psychopharmacology (Berl)       Date:  1994-05       Impact factor: 4.530

6.  Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol.

Authors:  J C Cole; R J Rodgers
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

7.  Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone.

Authors:  M Davis; J V Cassella; J H Kehne
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

8.  Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm.

Authors:  J H Kehne; J V Cassella; M Davis
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

9.  Potential anxiolytic properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin 1A receptor agonist.

Authors:  M Carli; R Samanin
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

10.  Metabotropic glutamate receptor subtype 5 (mGlu5) is necessary for estradiol mitigation of light-induced anxiety behavior in female rats.

Authors:  Christiana K Miller; Amanda A Krentzel; Heather B Patisaul; John Meitzen
Journal:  Physiol Behav       Date:  2019-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.